| Dr Michelle Lynn Winchell, DO | |
|
1 Elliot Way, Manchester, NH 03103-3502 | |
| (603) 669-5300 | |
| Not Available |
| Full Name | Dr Michelle Lynn Winchell |
|---|---|
| Gender | Female |
| Speciality | Critical Care (intensivists) |
| Experience | 9 Years |
| Location | 1 Elliot Way, Manchester, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679954713 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 21589 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southern Nh Medical Center | Nashua, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Foundation Medical Partners Inc | 9436140456 | 280 |
News Archive
The human body is engaged in a constant tightrope walk to maintain the right pH, because when our cells' acid-alkaline balance goes wrong, it can go wrong in a big way.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of chronic myeloid leukemia (CML).
Transposagen Biopharmaceuticals, a leader in genetic modification technology, announced today that it has entered into a non-exclusive license agreement with Cellular Dynamics International, the world's largest producer of human induced pluripotent stem cell lines and tissue cells for drug discovery and safety.
HIV positive patients who take combination antiretroviral therapy (cART) to combat HIV infection could see the numbers of CD4 cells in their immune system rise to concentrations found in HIV negative individuals, if they remain on the therapy for long enough and their HIV viral load load is suppressed to below 50 copies per ml.
› Verified 7 days ago
| Entity Name | Elliot Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285627935 PECOS PAC ID: 6103727920 Enrollment ID: O20040115000634 |
News Archive
The human body is engaged in a constant tightrope walk to maintain the right pH, because when our cells' acid-alkaline balance goes wrong, it can go wrong in a big way.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of chronic myeloid leukemia (CML).
Transposagen Biopharmaceuticals, a leader in genetic modification technology, announced today that it has entered into a non-exclusive license agreement with Cellular Dynamics International, the world's largest producer of human induced pluripotent stem cell lines and tissue cells for drug discovery and safety.
HIV positive patients who take combination antiretroviral therapy (cART) to combat HIV infection could see the numbers of CD4 cells in their immune system rise to concentrations found in HIV negative individuals, if they remain on the therapy for long enough and their HIV viral load load is suppressed to below 50 copies per ml.
› Verified 7 days ago
| Entity Name | Foundation Medical Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033162037 PECOS PAC ID: 9436140456 Enrollment ID: O20040519001048 |
News Archive
The human body is engaged in a constant tightrope walk to maintain the right pH, because when our cells' acid-alkaline balance goes wrong, it can go wrong in a big way.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of chronic myeloid leukemia (CML).
Transposagen Biopharmaceuticals, a leader in genetic modification technology, announced today that it has entered into a non-exclusive license agreement with Cellular Dynamics International, the world's largest producer of human induced pluripotent stem cell lines and tissue cells for drug discovery and safety.
HIV positive patients who take combination antiretroviral therapy (cART) to combat HIV infection could see the numbers of CD4 cells in their immune system rise to concentrations found in HIV negative individuals, if they remain on the therapy for long enough and their HIV viral load load is suppressed to below 50 copies per ml.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Lynn Winchell, DO 1 Elliot Way, Manchester, NH 03103-3502 Ph: () - | Dr Michelle Lynn Winchell, DO 1 Elliot Way, Manchester, NH 03103-3502 Ph: (603) 669-5300 |
News Archive
The human body is engaged in a constant tightrope walk to maintain the right pH, because when our cells' acid-alkaline balance goes wrong, it can go wrong in a big way.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that bafetinib (formerly known as INNO-406) has received official notification from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMEA) that a positive opinion was made regarding the application for orphan medicinal product for the treatment of chronic myeloid leukemia (CML).
Transposagen Biopharmaceuticals, a leader in genetic modification technology, announced today that it has entered into a non-exclusive license agreement with Cellular Dynamics International, the world's largest producer of human induced pluripotent stem cell lines and tissue cells for drug discovery and safety.
HIV positive patients who take combination antiretroviral therapy (cART) to combat HIV infection could see the numbers of CD4 cells in their immune system rise to concentrations found in HIV negative individuals, if they remain on the therapy for long enough and their HIV viral load load is suppressed to below 50 copies per ml.
› Verified 7 days ago
Jenny Lin, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500 | |
Dr. Douglas F. Marks Jr., M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 87 Mcgregor St, Ste 4100, Manchester, NH 03102 Phone: 603-695-2500 Fax: 603-695-2647 | |
Dr. Jose E. Lozano, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 718 Smyth Rd, Manchester Va, Manchester, NH 03104 Phone: 603-624-4366 | |
Frances Jensen, M.D. Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 456 Union St, Manchester, NH 03103 Phone: 866-679-0381 | |
Dr. Victor Gordan, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 718 Smyth Rd, Manchester, NH 03104 Phone: 603-624-4366 Fax: 603-626-6559 | |
Dr. Peter Wilson Shaw, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Mcgregor St # Stb, Manchester, NH 03102 Phone: 603-663-6350 | |
Dr. Goran Broketa, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 718 Smyth Rd, Manchester, NH 03104 Phone: 603-624-4366 Fax: 603-629-3217 |